CD36 and gastric cancer: In gastric cancer, CD36 promotes the uptake of exogenous palmitic acid to induce metastasis via the AKT/GSK-3β/β-catenin signaling pathway; therefore, targeting CD36 might constitute a promising new therapeutical approach for peritoneal metastases (12).